Receptor.AI Press Releases - EIN Presswire - Press Release Distribution Service

Published on December 15, 2022 - 12:29 GMT

The lipid membranes are druggable and available for AI-based drug design (acticle by Receptor.AI)

LONDON, UNITED KINGDOM, December 15, 2022 /⁨EINPresswire.com⁩/ -- Article 1: https://doi.org/10.3390%2Fpharmaceutics13040524 Article 2: https://doi.org/10.1016/j.bbadis.2022.166614 Are the lipid membranes druggable? Transmembrane proteins …

Distribution channels: Chemical Industry, Companies ...

Published on December 12, 2022 - 11:48 GMT

Receptor.AI helps fight obesity by acting on the “sixth taste” receptors

LONDON, UNITED KINGDOM, December 12, 2022 /⁨EINPresswire.com⁩/ -- A full text of the article can be found via the link: Obesity is one of the health problems which seems to be minor in comparison to cancer or neurodegenerative disorders from an …

Distribution channels: Chemical Industry, Companies ...

Published on November 28, 2022 - 15:35 GMT

DEL and AI: a marriage of convenience (article from Receptor.AI)

LONDON, LONDON, UNITED KINGDOM, November 28, 2022 /⁨EINPresswire.com⁩/ -- DELs in a nutshell DNA-encoded libraries are revolutionizing modern drug discovery by allowing an unprecedented amount of small molecules to be screened automatically. The …

Distribution channels: Chemical Industry, Companies ...

Published on August 28, 2022 - 16:08 GMT

The Proof of Excellence: comparative study of Receptor.AI virtual screening technologies

Comparative study of Receptor.AI virtual screening platform against 24 competing techniques. LONDON, UNITED KINGDOM, August 28, 2022 /⁨EINPresswire.com⁩/ -- All AI techniques rely on thorough validation, and AI-based drug discovery is no exception. …

Distribution channels: Chemical Industry, Companies ...

Published on August 28, 2022 - 16:05 GMT

Developing anticancer inhibitors of SIRT1 with RECEPTOR.AI SaaS Platform

LONDON, UNITED KINGDOM, August 28, 2022 /⁨EINPresswire.com⁩/ -- RECEPTOR.AI SaaS platform for drug discovery Our AI-based drug discovery platform allows virtual screening of billions of chemical compounds in just a few hours against the protein target of …

Distribution channels: Chemical Industry, Companies ...

Published on August 28, 2022 - 15:50 GMT

Developing novel inhibitors of BRD4 to fight leukaemia with RECEPTOR.AI SaaS Platform

LONDON, UNITED KINGDOM, August 28, 2022 /⁨EINPresswire.com⁩/ -- RECEPTOR.AI SaaS platform for drug discovery Our AI-based drug discovery platform allows virtual screening of billions of chemical compounds in just a few hours against the protein target of …

Distribution channels: Chemical Industry, Companies ...

Published on August 14, 2022 - 16:53 GMT

Can automated AI drug discovery platforms increase the confidence of pharma in AI techniques (report by Receptor.AI)

LONDON, UNITED KINGDOM, August 14, 2022 /⁨EINPresswire.com⁩/ -- There is no doubt that Artificial Intelligence is a disruptive technology for drug discovery. The AlphaFold alone, which de facto solved an eternal problem of the protein structure prediction, …

Distribution channels: Chemical Industry, Companies ...

Published on August 14, 2022 - 16:50 GMT

RECEPTOR.AI introduces SaaS platform for rapid and precise drug design

Receptor.AI announces the latest version of our AI-accelerated SaaS platform to disrupt drug discovery. LONDON, UNITED KINGDOM, August 14, 2022 /⁨EINPresswire.com⁩/ -- Receptor.AI is delighted to announce the launch of the SaaS platform for AI-accelerated …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on August 14, 2022 - 16:47 GMT

Undruggable targets: the major challenge for modern drug discovery (report by Receptor.AI)

The AI approaches for beating undruggability LONDON, UNITED KINGDOM, August 14, 2022 /⁨EINPresswire.com⁩/ -- The most frightening word in modern drug discovery is “undruggable”. This rather vague term means that it is notoriously hard or even impossible …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on February 17, 2022 - 13:02 GMT

Receptor.AI is working towards selective inhibitors of CLC-K chloride channels to fight hypertension

LEWES, DELAWARE, USA, February 17, 2022 /⁨EINPresswire.com⁩/ -- The CLC channels belong to a large family of ionic channels which translocate chloride ions across the cell membranes. In humans, the CLC channels are associated with several hereditary …

Distribution channels: Chemical Industry, Companies ...

Published on December 21, 2021 - 16:45 GMT

Receptor.AI Tests an Innovative Technique of Chemical Data Augmentation for Discovering Anti-Cancer Drugs

LEWES, DELAWARE, USA, December 21, 2021 /⁨EINPresswire.com⁩/ -- The BRD4 (Bromodomain-containing protein 4) protein is a transcriptional factor that plays an important role in cancer development. It has attracted a lot of attention in recent years as a …

Distribution channels: Chemical Industry, Companies ...

Published on November 9, 2021 - 16:47 GMT

Receptor.AI Develops Next Generation Drug Discovery Platform

This company announced AI solutions for the major stages of the drug discovery pipeline LEWES, DELAWARE, USA, November 9, 2021 /⁨EINPresswire.com⁩/ -- Artificial Intelligence is currently ubiquitous in drug discovery and is expected to revolutionize the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...